Health Trials

Large B Cell Diffuse Lymphoma

2

Review clinical trials related to Large B Cell Diffuse Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

This is a prospective, single-arm, multicenter, phase II clinical trial to evaluate the efficacy and safety of Relmacabtagene Autoleucel in combination with the Sintilimab regimen for the treatment of relapsed/refractory B-cell lymphoma

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Sun Yat-sen UniversityUpdated: Jan 21, 2026Locations: 3
Eligibility criteria

The patient must be aware of and voluntarily sign the informed consent form (ICF... [+8]

History of another malignancy that has not been in complete remission for at lea... [+12]

Read more
Status: Not yet recruiting

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

JWCAR239 is a CD19/CD20 CAR-T product. This trial is intended to evaluate the safety, PK/PD and efficacy of JWCAR239 in patients with B Cell Non-Hodgkin Lymphoma (B-NHL)

Participants needed: 20
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Peking University Cancer Hospital & InstituteUpdated: Jun 17, 2025Locations: 1
Eligibility criteria

Histologically confirmed B-NHL with immunohistochemical positivity for CD20 and/... [+6]

Lymphoma involving the central nervous system (CNS). [+12]

Read more